HopeStage
Back to overview

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Topics

More filters

Study design
Intervention type
Study phase

Recruiting now refers to the overall study. Local openings are shown only when the registry lists an open site.

1725studies shown
Showing 73-84 of 1,725
Drug study icon
RecruitingNCT07420283

Adding brenipatide or placebo to buprenorphine with or without naloxone for opioid use

About this title

A Study of Brenipatide in Participants With Opioid Use Disorder

Read the official source — NCT07420283
Official study title

A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study With a Separate Open-label Cohort to Evaluate the Efficacy and Safety of Brenipatide as Adjunctive Treatment to Transmucosal Buprenorphine With or Without Naloxone in Early Recovery of Participants With Opioid Use Disorder (RENEW-Op-1)

Recruiting in the United States
AddictionMedication studyAges 18–75
Countries
United States, Canada, United Kingdom
Sponsor
Eli Lilly and Company
Drug study icon
RecruitingNCT07219966

Brenipatide for moderate to severe alcohol use

About this title

A Study of Brenipatide in Participants With Moderate-to-Severe Alcohol Use Disorder

Read the official source — NCT07219966
Official study title

A Phase 3, Multicenter, Randomized, Double-Blind Study to Investigate the Efficacy and Safety of Brenipatide Compared With Placebo for the Treatment of Adult Participants With Moderate-to-Severe Alcohol Use Disorder (RENEW-ALC-1)

Recruiting in the United States
AddictionMedication studyAges 18–75
Countries
United States, United Kingdom, Belgium, + 5 others
Sponsor
Eli Lilly and Company
Biological study icon
RecruitingNCT03588975

MACI for OCD

Official study title

A Prospective, Open-label, Randomized, Concurrent Active-controlled, Longitudinal, Multicenter, Phase 3 Clinical Study of the Safety and Efficacy of MACI in Patients Aged 10 to 17 Years With Symptomatic Chondral or Osteochondral Defects of the Knee

Recruiting in the United States
OCDInterventional studyAges 10–17
Countries
United States
Sponsor
Vericel Corporation
Drug study icon
RecruitingNCT06655883

Suvorexant for insomnia in people with opioid use disorder

About this title

A Study of Suvorexant (MK-4305) for the Treatment of Insomnia Disorder in Participants With Opioid Use Disorder (MK-4305-098)

Read the official source — NCT06655883
What is this study about?

Researchers are comparing Suvorexant and placebo, tracking side effects to assess safety in people with opioid dependence.

Recruiting in the United States
AddictionMedication studyAges 18–70
Countries
United States
Sponsor
Merck Sharp & Dohme LLC
Drug study icon
RecruitingNCT05664516

Nasal oxytocin or placebo for adults with binge-eating episodes

About this title

A Study of the Effects of Oxytocin in Adults With Binge-eating Disorder

Read the official source — NCT05664516
Official study title

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effects of Intranasal Oxytocin in Adults With Binge-eating Disorder

Recruiting in the United States
Eating disordersMedication studyAges 18–70
Countries
United States
Sponsor
Massachusetts General Hospital (Hospital / academic medical center)

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.